Table 4 Organ dysfunction of critically ill patients in the 4 groups.
Total n = 807 | RSV group n = 151 | Covid-19 n = 332 | Seasonal influenza n = 258 | H1N1 influenza n = 66 | P | |
|---|---|---|---|---|---|---|
Invasive mechanical ventilation (IMV) | 476 (59) | 98 (65) | 181 (55) | 144 (56) | 55 (80) | < 0.001 |
IMV duration (days) | 10 [4; 21] | 4 [0; 8] | 19 [12; 31] | 8 [5; 15] | 12 [5; 22] | < 0.001 |
Neuromuscular blockade | 363 (45) | 67 (44) | 178 (54) | 80 (31) | 38 (57) | < 0.001 |
Duration of neuromuscular blockade (days) | 2 [1; 5] | 0 [0; 2] | 5 [2; 9] | 1 [1; 3] | 2 [1; 5] | < 0.001 |
Prone positioning | 242 (30) | 28 (18) | 150 (45) | 41 (16) | 23 (35) | < 0.001 |
HFNO | 324 (40) | 34 (22) | 202 (61) | 64 (25) | 24 (36) | < 0.001 |
Duration of HFNO (days) | 3 [2–5] | 2 [2–4] | 3 [2–6] | 2 [1–4] | 2 [1–2] | < 0.001 |
NIV | 399 (49) | 137 (90) | 87 (26) | 146 (57) | 29 (44) | < 0.001 |
Duration of NIV (days) | 3 [1; 5] | 3 [2; 4] | 2 [1; 4] | 2 [1; 5] | 4 [2; 4] | 0.104 |
ECMO | 17 (2) | 1 (1) | 9 (3) | 4 (2) | 5 (8) | 0.057 |
Beta agonists aerosols | 324 (40) | 89 (59) | 61 (18) | 131 (54) | 35 (53) | < 0.001 |
Duration (days) | 6 [3; 11] | 7 [5; 12] | 3 [1; 5] | 6 [3; 9] | 10 [4; 15] | < 0.001 |
anticholinergics aerosols | 154 (19) | 59 (39) | 26 (8) | 57 (22) | 12 (18) | < 0.001 |
Vasopressors | 471 (58) | 95 (63) | 184 (55) | 146 (57) | 46 (70) | 0.098 |
Duration of vasopressors (days) | 5 [2; 10] | 3 [0; 5] | 10 [5; 18] | 4 [2; 6] | 5 [3; 10] | < 0.001 |
RRT | 152 (19) | 23 (15) | 65 (20) | 38 (15) | 26 (39) | < 0.001 |
VAP | 144 (18) | 22 (15) | 78 (23) | 29 (11) | 15 (23) | < 0.001 |
Venous thrombo embolic complications | 79 (10) | 7 (5) | 53 (16) | 15 (6) | 4 (6) | < 0.001 |
